Market Overview

Exagen Diagnostics to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum


Albuquerque, NM and San Diego, CA, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Exagen Diagnostics, a leader in autoimmune life sciences, today announced that President and Chief Executive Officer, Ron Rocca, will present at the Canaccord Genuity Medical Technologies & Diagnostics Forum to be held in New York, NY at the Westin Grand Central Hotel on Thursday, November 15, 2018 at 11:30 a.m. Eastern Time. Mr. Rocca will present an overview of the patented cell-bound complement activation products (CB-CAPs) technology and other recent advances for the AVISE®  brand of testing.

About Exagen
Exagen is a commercial stage life sciences company that is patient focused, and discovery driven. Exagen serves patients and healthcare providers across the U.S. in the diagnosis, prognosis, and management of lupus, rheumatoid arthritis, and other autoimmune conditions. By leveraging our patented and validated CB-CAPs technology we can help get to the real cause of a patient's symptoms and guide their journey to improved health. For more information, visit or follow us on FacebookTwitterYouTubeLinkedIn, or Instagram.


Kamal Adawi
Exagen Diagnostics, Inc.

View Comments and Join the Discussion!

Latest Ratings

View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.